DNDN
DNDN Articles
This Week’s Top Seven Issues (June 8, 2007) 1) THE ROLLER-COASTER MARKETThanks a lot Bill Gross. You’re sounding more like Greenspan now that you have him on your advisory board at PIMCO. ...
Published:
Last Updated:
Dendreon (DNDN-NASDAQ) announced this morning that it did price its $75 million in convertible senior subordinated notes due 2014 via a Rule 144A private placement. The interest rate is merely...
Published:
Shares of Dendreon (DNDN) are trading down some 7% pre-market after the company announced that it was going to offer $75 million in convertible senior subordinated notes that are due in 2014. The...
Published:
Banc of America has noted that yesterday’s ‘positive data’ is actually not new and that the interim data will not be available until the second half of 2008. Mitchell Gold, MD/PhD/CEO of...
Published:
Dendreon (DNDN-NASDAQ) is benefitting from something that become thought of as a low probability event: an FDA that buckled at least a little to peer pressure. It has received confirmation that...
Published:
This weekend we have the mother of all future cancer treatment conferences: ASCO, or The American Society of Clinical Oncology. Cancer stocks in the last few weeks have been seeing a muted response...
Published:
Novacea (NOVC-NASDAQ) is seeing its shares up more than 70% after signing a pact with Schering-Plough (SGP-NYSE) over the development and commercialization of Asentar for the treatment of prostate...
Published:
(AAPL) Apple trading up 0.5% after Morgan Stanley raised its $110 target to $150.(BGP) Borders Group posted a -$0.51 EPS loss vs. -$0.38e.(BIIB) Biogen Idec announced up to $3 Billion in share...
Published:
If you thought the day would never come that Dendreon (DNDN-NASDAQ) would see its volatility, its hyperactive volume, and its options premium compress to something back to almost normal, guess again:...
Published:
Last Updated:
Stock Tickers: DNA, AMGN, NFLD, CELG, GILD, GENZ, ONXX, DNDN Jim Cramer has a video on TheStreet.com "Wall St. Confidential" showing how the biotech sector can be looked at with blow-ups. For every...
Published:
Stock Tickers: AMGN, GILD, CELG, GENZ, MEDI, BIIB, AMLN, IMCL, DNDN, NFLD The short interest is on the rise overall, but the odd thing is that the short interest in biotech shares is really a mixed...
Published:
Dendreon Corp. (DNDN-NASDAQ) was downgraded from an “Outperform” rating to a “Market Perform” rating. The brokerage sees uncertainties and risks going into an expected meeting FDA meeting...
Published:
BF/B started as Buy at A.G.Edwards.BMO raised to Outperform at CIBC.DNDN downgraded to Mkt Perform at JMP Securities.GNVC started as Buy at Stifel Nicolaus.INSU started as Neutral at RWBaird.MPW...
Published:
Since Dendreon (DNDN) has gotten a bit of life this week, there have been numerous inquiries as to "Where is this stock going?" from stock investors. There is obviously some hope by investors that...
Published:
Dendreon (DNDN-NASDAQ) has an interesting twist this morning because of two issues. Yesterday it announced some new study data on PROVENGE at The American Urological Association on Sunday. The...
Published: